Lineage Cell Therapeutics Inc (LCTX)

[Stock Guy777]

View this email in your browser
BioTime CEO Dr. Michael D. West to Discuss BioTime's Growth, Cell-Based Therapies and Diagnostics on Bloomberg Radio's "The Bloomberg Advantage”

Interview Airs Tomorrow, Wednesday March 25 at 1:00 pm EDT/10:00 am PDT




BioTime, Inc. (NYSE MKT: BTX), a pioneer in regenerative medicine and a clinical-stage biotechnology company, today announced that Dr. Michael D. West, CEO of BioTime, will be interviewed on Bloomberg Radio's "The Bloomberg Advantage” hosted by Kathleen Hays and Vonnie Quinn. In this exclusive interview, Dr. West will discuss the Company's growth and plans to advance development of BioTime and its subsidiaries' cell-based therapies and gene marker-based molecular diagnostics that address unmet medical needs with large market potential. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Sirius XM Channel 119, 1130 AM in New York, 1200 AM in Boston, 960 AM or 103.7 FM-HD2 in San Francisco, or online at Bloomberg.com/radio or via the Bloomberg Radio app.



Date: Wednesday, March 25, 2015
Start Time: 1:00 pm EDT / 10:00 am PDT
Network: Bloomberg Radio

Show: The Bloomberg Advantage

Hosts: Kathleen Hays and Vonnie Quinn

Live Stream: http://www.bloomberg.com/radio/




Issuer Direct Corporation, 500 Perimeter Park Drive, Suite D, Morrisville, NC 27560, USA
Unsubscribe me
Update Preferences